Literature DB >> 7393351

Arachidonic acid-induced malondialdehyde formation in rat platelets. Kinetic aspects and inhibition by acetylsalicylic acid and indomethacin.

G de Gaetano, G Rajtar, M Livio, J Merino.   

Abstract

Malondialdehyde (MDA) is a stable product of arachidonic acid metabolism, catalyzed by the enzyme cyclo-oxygenase. The experimental conditions for measuring the kinetic of MDA formation in rat platelet-rich plasma were defined. In platelets stimulated with arachidonic acid MDA formation was almost linear for a limited period of time (between 0 and 2 min) and was concentration-dependent with saturation kinetics. The hyperbolic curves obtained were recast in a linear plot (according to transformation S/V versus S) and straight lines fitting all experimental points were obtained. The apparent Km value of arachidonic acid was 0.49 +/- 0.09 mM and Vmax 1.44 +/- 0.06 nmoles MDA/1.4 x 10(9) platelets/min. The apparent type of inhibition and the relative potency of acetylsalicylic acid and indomethacin on MDA formation were also investigated. Inhibition by both drugs was concentration-dependent, and was much stronger when either drug was preincubated with platelets for 10 min than for 1 min. Analysis of the data by Dixon plots (1/V versus inhibitor concentrations) revealed an apparently competitive type of inhibition. It is suggested that both acetylsalicylic acid and indomethacin inhibit cyclo-oxygenase in platelet-rich plasma by a similar mechanism, not involving covalent binding of either drug to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7393351     DOI: 10.1007/bf00502579

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  Pharmacological properties of drug inhibiting platelet aggregation.

Authors:  G de Gaetano
Journal:  Acta Clin Belg       Date:  1975       Impact factor: 1.264

3.  Effect of anti-inflammatory agents on platelets.

Authors:  J R O'Brien
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

4.  Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin.

Authors:  J J Kocsis; J Hernandovich; M J Silver; J B Smith; C Ingerman
Journal:  Prostaglandins       Date:  1973-02

5.  Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.

Authors:  J Merino; M Livio; G Rajtar; G de Gaetano
Journal:  Biochem Pharmacol       Date:  1980-04-15       Impact factor: 5.858

6.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

7.  Arachidonic acid-induced human platelet aggregation and prostaglandin formation.

Authors:  M J Silver; J B Smith; C Ingerman; J J Kocsis
Journal:  Prostaglandins       Date:  1973-12

8.  Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.

Authors:  M Wielosz; M Salmona; G de Gaetano; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

9.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

10.  Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  2 in total

1.  Effect of SAS 650 (Furofenac) on malondialydehyde production by platelets.

Authors:  G P Corbelli; L Stanzani; R Mastacchi; M Barbanti; L Montecchi
Journal:  Agents Actions       Date:  1984-06

Review 2.  An Evaluation of the Role of Oxidative Stress in Non-Obstructive Coronary Artery Disease.

Authors:  Nurnajwa Pahimi; Aida Hanum Ghulam Rasool; Zulkefli Sanip; Nur Adilah Bokti; Zurkurnai Yusof; W Yus Haniff W Isa
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.